You are viewing the site in preview mode
Skip to main content
|
Microbial skin counts/pathogensa
|
Timing
|
P-value for difference (paint 2 vs. 3)
|
|---|
|
Prior to skin antisepsisb
|
After 2nd paint
|
After 3rd paint
|
|---|
|
Overall
|
|
\( \sqrt{\mathrm{CFU}}, \) mean (SD)
|
11.2 (47.5)
|
0.5 (5.5)
|
0.1 (0.6)
|
0.2
|
|
CFU, median
|
7.0
|
0.0
|
0.0
|
0.002
|
|
CFU, IQR
|
1.0 to 79.8
|
0.0 to 0.0
|
0.0 to 0.0
|
|
CFU, range
|
0.0 to 50,000.0
|
0.0 to 7000.0
|
0.0 to 33.0
|
|
No. patients with 0 CFU (%)
|
30 (12.6)
|
203 (86.0)
|
224 (94.5)
|
0.003
|
|
No. patients with > 5 CFU (%)
|
126 (52.9)
|
5 (2.1)
|
3 (1.3)
|
0.9
|
|
No. patients with ≥1 pathogensc detected (%)
|
1 (0.4)
|
1 (0.4)
|
0 (0)
|
0.5
|
|
No. patients with insufficient microbial reductiona,d (%)
|
0 (0)
|
6 (2.5)
|
3 (1.3)
|
0.5
|
|
Povidone iodine subgroup
|
|
\( \sqrt{\mathrm{CFU}}, \) mean (SD)
|
13.7 (60.2)
|
0.9 (7.0)
|
0.2 (0.72)
|
0.2
|
|
CFU, median
|
8.5
|
0.0
|
0.0
|
0.002
|
|
CFU, IQR
|
1.0 to 84.0
|
0.0 to 0.0
|
0.0 to 0.0
|
|
CFU, range
|
0.0 to 50,000.0
|
0.0 to 7000.0
|
0.0 to 33.0
|
|
No. patients with 0 CFU (%)
|
18 (12.5)
|
114 (80.2)
|
133 (93.0)
|
0.002
|
|
No. patients with > 5 CFU (%)
|
80 (55.2)
|
5 (3.5)
|
3 (2.1)
|
0.7
|
|
No. patients with ≥1 pathogensc detected (%)
|
1 (0.7)
|
1 (0.7)
|
0 (0)
|
0.7
|
|
No. patients with insufficient microbial reductiona,d (%)
|
0 (0)
|
6 (4.2)
|
3 (2.1)
|
0.5
|
|
Chlorhexidine subgroup
|
|
\( \sqrt{\mathrm{CFU}}, \) mean (SD)
|
7.5 (12.4)
|
0.1 (0.3)
|
0.03 (0.2)
|
0.4
|
|
CFU, median
|
5.5
|
0.0
|
0.0
|
0.5
|
|
CFU, IQR
|
1.0 to 60.0
|
0.0 to 0.0
|
0.0 to 0.0
|
|
CFU, range
|
0.0 to 5000.0
|
0.0 to 2.0
|
0.0 to 1.0
|
|
No. patients with 0 CFU (%)
|
12 (12.8)
|
89 (95.0)
|
91 (97.0)
|
0.7
|
|
No. patients with > 5 CFU (%)
|
46 (48.9)
|
0 (0)
|
0 (0)
|
─
|
|
No. patients with ≥1 pathogensc detected (%)
|
0 (0)
|
0 (0)
|
0 (0)
|
─
|
|
No. patients with insufficient microbial reductiona,d (%)
|
0 (0)
|
0 (0)
|
0 (0)
|
─
|
- Among the 239 individuals, CFU data were overall missing for 1 patient at baseline, for 3 patients after paint 2, and for 2 patients after paint 3
- CFU colony forming units, IQR interquartile range, SD standard deviation
- aIn the antiseptic area (template window area, 25 cm2)
- bImmediately before preoperative skin antisepsis (first paint)
- cPathogen defined according to the National Healthcare Safety Network common commensals/pathogen list (version 9.2; www.cdc.gov)
- dInsufficient reduction was defined as detection of > 5 colony forming units and/or ≥ 1 pathogens in the examined, antiseptic area